Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]



A substrate-competitive SMYD3 inhibitor
Catalog #: B3251
SKU-Size Size Price Qty
B3251-5 5 mg
B3251-25 25 mg
More Sizes Get Quote

Product Details

Alternate Name BCI121; 4-(Aminocarbonyl)-N-(4-bromophenyl)-1-piperidineacetamide
Peptide Sequence N/A
Appearance White to off-white solid
CAS # 432529-82-3
Molecular Formula C₁₄H₁₈BrN₃O₂
Molecular Weight 340.22
Purity ≥98% by HPLC
Solubility ~20 mg/ml DMSO
InChi InChI=1S/C14H18BrN3O2/c15-11-1-3-12(4-2-11)17-13(19)9-18-7-5-10(6-8-18)14(16)20/h1-4,10H,5-9H2,(H2,16,20)(H,17,19)
PubChem CID 795875
Handling Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


BCI-121 is a substrate-competitive SMYD3 inhibitor that reduces nuclear histone H3 lys4 di- and tri-methylation level, downregulates known SMYD3 target genes transcription, and selectively affects SMYD3-dependent proliferation of cancer cultures with little antiproliferation efficacy toward low SMYD3-expressing cancer cells.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.